Director at a Fortune 5 company, Michael brings 10 years of experience in business innovation and development spanning biopharma, payers, medical devices and retail healthcare leveraging an engineering and life sciences background. Excels at bringing leadership together from external organizations including heads of NIH, CDC, BARDA, Gates Foundation, biopharma and patient advocacy groups to advance joint partnership opportunities. Michael has experience across disease and therapeutic areas. Through developing strategic partnerships with innovative biopharma organizations, Michael leads new initiatives to support biopharma commercialization and clinical development. With robust experience and background in bioengineering, Michael has completed an MBA in Finance to continue leadership in healthcare strategy and business development. Over the past few years, Michael has helped initiate a new business unit out of CVS corporate strategy to provide clinical trial services by leveraging CVS-Aetna assets.